How we diagnose and define obesity is set to change – here’s why, and what it means for treatment
Obesity is linked to many common diseases, such as type 2 diabetes, heart disease, fatty liver disease and knee osteoarthritis.
Opinions
New twin study links fruit and vegetable consumption to reduced depression risk
New research led by the Centre for Healthy Brain Ageing at UNSW, published in Scientific Reports, highlights the potential protective role of fruit and vegetable consumption against depression. Utilising data from four international twin cohorts, the study addresses longstanding questions about the impact of diet on mental health by leveraging twin studies to minimise confounding factors.
Clinicians and digital health: tackling the last mile problem
The successful implementation and uptake of health technologies in real-world settings remain an ongoing challenge. Clinicians have an essential role to play in facilitating successful digital health design and implementation.
Flipping the script on loneliness with green prescriptions
Green prescriptions — a prescription for an individual to step outside and spend time in nature and community — are an effective, inexpensive way to ease the burden of loneliness.
The entwinement of social determinants of health, the social model of disability and the Disability Royal Commission
The medical profession must understand and addresses the social influences on the lives of people with disability in order to improve the health, wellbeing and lives of people with disability.
What to do with the mountains of plastic waste in health care?
The health care sector is a substantial contributor to the plastic pollution crisis due to our reliance on single-use plastic packaging.
This is our lane: why doctors must care about climate change
As doctors, we must use our powerful voices to communicate climate threats and solutions clearly, and demonstrate how deeply we care about addressing the climate impacts on the health of Australians.
Long COVID appears to be driven by ‘long infection’. Here’s what the science says
Around 5–10% of people with COVID infections go on to experience long COVID, with symptoms lasting three months or more.
A great challenge: implementation of SGLT2 inhibitors and GLP-1 receptor agonists for type 2 diabetes
SGLT2 inhibitors and GLP-1 receptor agonists represent significant advances in the treatment of type 2 diabetes, but there are challenges in providing equitable access to these medicines.
